FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes ...
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
FDA Approves Ozempic to Treat Kidney Disease
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
infectiousdiseaseadvisor.com2 天
Ozempic Approval Expanded to Include T2D Patients With Chronic Kidney Disease
The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...
The Baltimore Sun3 天
FDA approves Ozempic to help reduce risk of worsening chronic kidney disease
Ozempic, the GLP-1 drug initially approved by the U.S. Food and Drug Administration in 2017 to treat Type 2 diabetes, was recently OK’d to help reduce risks linked to chronic kidney disease (CKD).
KOAT Albuquerque5 天
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
about a third of adults with diabetes also have chronic kidney disease, according to the U.S. Centers for Disease Control and PreventionThe clinical trial tested the efficacy of Ozempic when added ...